The United Kingdom is witnessing an alarming surge in norovirus infections that has led the National Health Service (NHS) to take extreme action. With multiple wards at Bedford Hospital in the Highlands shutting their doors to new admissions and restricting visitors, the outbreak has rapidly grown into a public health issue that has echoed far beyond British shores. Health officials and epidemiologists are cautioning that this could be just the start of a second wave of infections—fueled by changing viral strains and a lack of population immunity.
As health systems around the world continue to struggle with pandemic fatigue and systemic strain, the norovirus comeback provides a timely reminder: hygiene, surveillance, and public awareness are still pillars of infectious disease prevention.
The Bedford Hospital outbreak is not unique. As reported by the UK Health Security Agency (UKHSA), norovirus cases have increased dramatically since February, hitting record levels since the agency started collecting comparative data in 2014. NHS England said hospitalizations for the virus have jumped to an average of 1,134 patients per day—nearly twice as many as the same time last year.
The GII.17 strain, which was the predominant genotype for the first half of the winter, comprised 59% of cases reported. Its prevalence fell from 76% in November, however, and was replaced by the GII.4 strain, which increased from 10% to 29% over the past three months. The shift in strains may imply that people who were infected with one strain remain susceptible to another, making containment and immunity difficult.
Traditionally referred to as the "winter vomiting bug," norovirus is a highly contagious virus that causes acute gastroenteritis or inflammation of the stomach and intestines. It infects others quickly through food, water, surfaces, and contact with other people. Typical symptoms include sudden nausea, vomiting, diarrhoea, cramping of the abdomen, and sometimes low-grade fever, aches, and headaches.
Unlike influenza, norovirus does not yield to antiviral drugs. It typically lasts for 1–3 days, but the illness can be particularly severe in young children, older adults, and those with compromised immune systems because of the danger of dehydration.
Bedford Hospital's action in closing off affected wards and restricting visiting is in line with the high transmissibility of norovirus, especially in closed settings such as hospitals and care homes. Amy Douglas, UKHSA Lead Epidemiologist, emphasized that the presence of several genotypes simultaneously raises the risk of reinfection, placing a further burden on already overcrowded hospitals running with 95.3% adult beds in use.
Saffron Cordery, NHS Providers' acting chief executive, shared the concern, pointing to high pressure on emergency services, loss of paramedic hours due to ambulance handover delays, and delays in discharging clinically ready patients—a perfect storm that could overwhelm the system.
While the outbreak at present is focal in the UK, the potential for international spread is considerable. The characteristics of international travel, climate fluctuations, and high-density urban living allow norovirus to spread freely across borders. Based on estimates, for each laboratory-confirmed case in the UK, there are around 288 unreported community cases, suggesting a possible national burden of more than 3 million cases per year.
This is a cause for concern for health authorities across the globe. Outbreaks in closed and semi-closed settings such as schools, cruise ships, nursing homes, and healthcare facilities can lead to rapid spread and high absenteeism.
Although there is no vaccine available for norovirus at the moment, there are definite measures that one can take to reduce risk:
Hand sanitizers work very poorly on norovirus. Wash your hands frequently with soap and warm water, particularly after going to the toilet, after handling dirty diapers, and before preparing food or eating.
In case you are vomiting or experiencing diarrhoea, avoid handling food for others for a period of at least 48 hours after your symptoms have ceased. This is when you're most contagious still.
Use bleach-based cleaners to clean kitchen counters, bathroom faucets, and high-touch surfaces. Norovirus lasts for days on surfaces if not sanitized.
As a student, employee, or caregiver, it's imperative you quarantine yourself for a minimum of 48 hours after the symptoms have disappeared to avoid infecting others.
Vomiting and diarrhoea can lead to rapid dehydration. Increase fluid intake with water, oral rehydration salts, or electrolyte drinks. Watch for signs of severe dehydration—dry mouth, dizziness, and low urine output—and seek medical attention if they occur.
The UK government is taking preventative measures, such as introducing RSV vaccination campaigns and new hospital guidelines. Experts, however, say that in the absence of public compliance and hygiene awareness, such outbreaks can become the norm.
NHS England's National Medical Director, Professor Sir Stephen Powis, appealed to the public to use NHS 111 and its website for non-emergency questions to take the strain off emergency departments.
Health and Social Care Secretary Wes Streeting recognized the continued pressure and reconfirmed the government's promise to reform the system: "These figures indicate that we are not yet out of the winter woods yet."
The surge of norovirus infections in the UK is a stark reminder of how rapidly an infection that's seasonal can quickly become a national health issue. It demands increased vigilance about hygiene, infection control, and healthcare system strength—not only in the UK but everywhere.
Credit: UNIGME
With interventions targeted towards improving maternal and child health along with quality and accessible health infrastructure, India has played a crucial role in the decline of global child mortality, especially in South Asia, according to a UN report today.
The UN Inter-agency Group for Child Mortality Estimation (UNIGME) Report 2025 highlighted that the country's sustained efforts in the last two decades in child health have led to significant outcomes in South Asia. They include:
"India emerges as a leading global exemplar in the UN IGME 2025 report for accelerating child mortality reduction," JP Nadda, Union Health Minister, shared in a post on X.
"India’s focussed comprehensive approach on neonatal care has paved the way for eliminating preventable child deaths and securing healthy future for our children," he added.
Also read: 4.9 Million Children Died Before Age Five Worldwide In 2024: UN Report
In India, the UNIGME report showed that:
The report lauded India’s "continuum-of-care strategy" that has integrated sustained strengthening of a vibrant health system with commensurate expansion of its health infrastructure.
It also hailed demand-driven programmatic interventions in reducing preventable maternal and newborn mortality. These include:
Further, it noted that India’s commitment to improving newborn and child survival has also been reflected in continuous quality improvement initiatives such as the recently released guidelines on Facility-Based Newborn Care (FBNC) and
digital innovations such as Tele-SNCU (HUB & SPOKE model).
These efforts are complemented by hybrid skill-based learning modules on the safe and rational use of oxygen (including CPAP) and by the empowerment of mothers and caregivers to provide nurturing care to small and sick newborns.
"India is among the first few countries to set targets and release operational guidelines on Stillbirth Surveillance and response," the report said.
The UN noted that India’s experience shows that "sustained leadership, strategic investments, and strong collaboration with committed stakeholders have enabled a robust, scalable, and effective implementation framework targeted towards the achievement of the SDGs".
Credit: Sansad TV/X
Finance Minister Nirmala Sitharaman has announced in the Parliament that India is planning to launch universal health coverage for all by 2033.
Addressing the Rajya Sabha, the Finance Minister stated that health insurance has become a priority area for the government, and informed that the sector has made significant progress, covering 58 crore lives in 2024–25, news agency PTI reported.
“Health insurance is a priority for this government. In fact, we are hoping that by 2033 we will have insurance cover for all,” Sitharaman said.
The FM added that the total health premium collections in the country reached Rs 1,17,505 crore in 2024–25. The health premiums under
“Health insurance is now a clear priority with GST exemption on individual premiums, expansion of coverage, and strong regulatory push driving the momentum,” she said.
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the world’s largest publicly funded health insurance scheme, launched in 2018, provides health cover of Rs 5 lakh per family per year. It provides secondary and tertiary care hospitalization to about 12 crore families, representing the bottom 40 per cent of the population.
The scheme was further expanded to cover 6 crore senior citizens of age 70 years and above, belonging to 4.5 crore families, irrespective of their socio-economic status.
Union Minister of State for Health and Family Welfare, Prataprao Jadhav, stated in a written reply in the Rajya Sabha that
till February 28:
Further, the latest national master of Health Benefit Package provides cashless healthcare services for 1,961 procedures across 27 medical specialties.
“A total of 11.69 crore hospital admissions amounting to Rs. 1.73 lakh crore have been authorized under the scheme,” Jadhav said.
He added that more than 86 crore Ayushman Bharat Health Accounts (ABHA) have been created, and more than 90 Crore health records have been linked to patients’ ABHA.
In addition, Ayushman Bharat Digital Mission (ABDM) was launched in India in September 2021 to support the development of an integrated and citizen-centric national digital health ecosystem.
Till March 11, the progress made under ABDM includes:
Credit: iStock
India’s Human Papillomavirus (HPV) vaccination drive that began a fortnight ago has already vaccinated nearly 3 lakh girls aged 14 years, according to the Union Health Ministry.
The nationwide free HPV vaccination campaign for girls aged 14 years was launched by Prime Minister Narendra Modi from Rajasthan's Ajmer on February 28.
“Within just a fortnight of its launch, nearly 3 lakh girls aged 14 years have already been vaccinated—marking an encouraging start to this critical public health initiative,” the health ministry said.
"The enthusiastic participation seen so far reflects growing awareness among parents, schools, and communities about the importance of early protection," it added.
Further, the Ministry noted that several states, including Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Gujarat, Odisha, and Mizoram, have seen a significant uptake in the nationwide HPV vaccination campaign.
The initiative marked a decisive step towards eliminating cervical cancer through timely HPV vaccination.
Cervical cancer remains the second most common cancer among women in India. Nearly 80,000 new cases and over 42,000 deaths are reported annually in the country.
The Ministry said that despite examinations currently underway in many regions, the response to the campaign has remained strong, and the momentum is expected to accelerate significantly in the coming days.
“We are leaving no stone unturned to ensure that the daughters of the country are healthy and prosperous. The objective of this initiative is the prevention of cervical cancer," the Prime Minister, earlier wrote in a post on social media platform X.
The government has urged parents and guardians to support and encourage eligible girls to get vaccinated at the earliest.
HPV vaccination is voluntary, and parental consent is mandatory before administration of the vaccine.
The single-dose Gardasil-4 vaccine is administered free of cost at government health facilities across all areas, including rural and underserved areas, and will be available even after the campaign ends.
The vaccine used is non-live and does not cause HPV infection. It is supported by more than 500 million doses administered globally since its introduction in 2006.
The vaccine is most effective when it is administered before exposure to HPV and before becoming sexually active. Young women aged 9 to 14 years show vaccine effectiveness of 74 to 93 per cent and this decreases with age.
To avail the free HPV vaccine, visit any government health facilities including
© 2024 Bennett, Coleman & Company Limited